Clinical Trials for Cytokinetics

Explore 6 clinical trials worldwide

Showing 1-6 of 6 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Cytokinetics

Clinical Trials (6)

NCT07054073
HCMR Re-Imaging Study
N/ANot yet recruiting
314 participants
Started: Jul 30, 2025 · Completed: Jul 31, 2026
1 condition12 sponsors8 locations
NCT06793371
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
PHASE2Recruiting
60 participants
Started: Feb 6, 2025 · Completed: Sep 30, 2026
1 condition1 sponsor20 locations
NCT06736574
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
PHASE3Recruiting
1,800 participants
Started: Dec 19, 2024 · Completed: Dec 31, 2027
2 conditions1 sponsor77 locations
NCT06412666
A Study to Evaluate the Effect of Aficamten in Pediatric Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM).
PHASE2/PHASE3Recruiting
40 participants
Started: May 29, 2024 · Completed: Jan 31, 2030
2 conditions1 sponsor38 locations
NCT06081894
Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic nHCM
PHASE3Recruiting
500 participants
Started: Aug 30, 2023 · Completed: Sep 30, 2026
1 condition3 sponsors135 locations
NCT04848506
Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM
PHASE2/PHASE3Enrolling by invitation
900 participants
Started: May 6, 2021 · Completed: Mar 31, 2028
1 condition1 sponsor90 locations